1. Home
  2. VVOS vs BOLT Comparison

VVOS vs BOLT Comparison

Compare VVOS & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • BOLT
  • Stock Information
  • Founded
  • VVOS 2016
  • BOLT 2015
  • Country
  • VVOS United States
  • BOLT United States
  • Employees
  • VVOS N/A
  • BOLT N/A
  • Industry
  • VVOS Medical Specialities
  • BOLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • VVOS Health Care
  • BOLT Health Care
  • Exchange
  • VVOS Nasdaq
  • BOLT Nasdaq
  • Market Cap
  • VVOS 14.8M
  • BOLT 16.8M
  • IPO Year
  • VVOS 2020
  • BOLT 2021
  • Fundamental
  • Price
  • VVOS $3.28
  • BOLT $5.69
  • Analyst Decision
  • VVOS Strong Buy
  • BOLT Buy
  • Analyst Count
  • VVOS 2
  • BOLT 3
  • Target Price
  • VVOS $6.10
  • BOLT $50.00
  • AVG Volume (30 Days)
  • VVOS 236.5K
  • BOLT 23.5K
  • Earning Date
  • VVOS 08-13-2025
  • BOLT 08-12-2025
  • Dividend Yield
  • VVOS N/A
  • BOLT N/A
  • EPS Growth
  • VVOS N/A
  • BOLT N/A
  • EPS
  • VVOS N/A
  • BOLT N/A
  • Revenue
  • VVOS $14,628,000.00
  • BOLT $3,638,000.00
  • Revenue This Year
  • VVOS $17.40
  • BOLT N/A
  • Revenue Next Year
  • VVOS $10.78
  • BOLT $24.14
  • P/E Ratio
  • VVOS N/A
  • BOLT N/A
  • Revenue Growth
  • VVOS 9.47
  • BOLT N/A
  • 52 Week Low
  • VVOS $1.97
  • BOLT $5.20
  • 52 Week High
  • VVOS $6.28
  • BOLT $15.60
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 70.72
  • BOLT 42.69
  • Support Level
  • VVOS $2.03
  • BOLT $5.36
  • Resistance Level
  • VVOS $3.91
  • BOLT $6.07
  • Average True Range (ATR)
  • VVOS 0.26
  • BOLT 0.44
  • MACD
  • VVOS 0.13
  • BOLT -0.01
  • Stochastic Oscillator
  • VVOS 66.49
  • BOLT 25.58

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Share on Social Networks: